TITLE

Replacing Urine Protein Electrophoresis With Serum Free Light Chain Analysis as a First-Line Test for Detecting Plasma Cell Disorders Offers Increased Diagnostic Accuracy and Potential Health Benefit to Patients

AUTHOR(S)
McTaggart, Malcolm P.; Lindsay, Jindriska; Kearney, Edward M.
PUB. DATE
December 2013
SOURCE
American Journal of Clinical Pathology;Dec2013, Vol. 140 Issue 6, p890
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: To determine the most clinically effective diagnostic testing strategy for plasma cell disorders in the clinical laboratory. Methods: Serum and urine samples from 2,799 patients with suspected plasma cell dyscrasias were tested by alternative diagnostic testing strategies consisting of serum protein electrophoresis (SPE) with either urine protein electrophoresis (UPE) or serum free light chain (sFLC) analysis. Results: The combination of sFLC analysis and SPE had the greatest sensitivity (100%), detecting abnormalities in all 124 patients diagnosed with plasma cell disorders. Routine sFLC testing would have had much potential health benefit for two patients in the study population. First, a patient who had a markedly abnormal sFLC result was diagnosed with light chain deposition disease by renal biopsy, but no abnormality was detected by SPE or UPE. Second, a patient diagnosed with multiple plasmacytomas following biopsy of a lung tumor had a grossly abnormal sFLC result but an equivocal weak-positive SPE result, and no urine sample was received by the laboratory for the patient. Conclusions: Our study suggests that the combination of SPE and sFLC analysis is the most clinically effective first-line diagnostic testing strategy for detecting plasma cell disorders in the clinical laboratory.
ACCESSION #
91961374

 

Related Articles

  • Evaluation of response to arsenic trioxide in patients with refractory multiple myeloma. Sanaat, Zohreh; Rezazadeh, Mahtab; Gharamaleki, Jalil Vaez; Ziae, Jamal Eivazi; Esfahani, Ali; Ghojazadeh, Morteza // Tehran University Medical Journal;Mar2010, Vol. 67 Issue 12, p843 

    Background: Multiple myeloma is a plasma cell dyscrasia characterized by proliferation of plasma cells in bone marrow associated with the production of monoclonal immunoglobulins. In recent years, the use of arsenic trioxide, formerly approved for treatment of acute promyelocytic leukemia has...

  • Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy. Hutchison, Colin A.; Cockwell, Paul; Cook, Mark // BMC Clinical Pathology;2012, Vol. 12 Issue 1, p12 

    Background: The development of serum immunoassays for the measurement of immunoglobulin free light chains has led to a paradigm shift in the diagnosis, assessment and monitoring of patients with plasma cell dyscrasias. The impact of these immunoassays which employ polyclonal antibodies was most...

  • Detection of free light chain monoclonal proteins co-migrating with intact monoclonal proteins in patients with monoclonal gammopathy. Wetenhall, Kate; Saleem, Rehana; Rowbottom, Anthony // Annals of Clinical Biochemistry;Nov2012, Vol. 49 Issue 6, p603 

    Background: In a small, but potentially significant proportion of patients with a monoclonal gammopathy, patients show the existence of an intact monoclonal (M-) protein co-migrating with a free light chain (FLC) M-protein. Using traditional methods for detection of monoclonal immunoglobulins,...

  • Protein Electrophoresis and Immunofixation for the Diagnosis of Monoclonal Gammopathies. Rajkumar, S. Vincent; Kyle, Robert A. // JAMA: Journal of the American Medical Association;11/26/2014, Vol. 312 Issue 20, p2160 

    The article reviews the application of urine protein electrophoresis and serum immunofixation in the case of a woman in her 70s who was diagnosed with monoclonal gammopathy of undetermined significance (MGUS). Data provided shows the patient's laboratory values and describes the characteristics...

  • The Scratch Test. Pantanowitz, Liron; Miller, Kenneth B.; Ford, Jason C.; Beckwith, Bruce A. // Archives of Pathology & Laboratory Medicine;May2004, Vol. 128 Issue 5, p598 

    The article presents outcomes of scratch test performed for a 47 year old patient suffering from plasma cell myeloma. He was noted to have 9660 mg/dL of monoclonal immunoglobulin G in her serum. T high concentration of paraprotein also resulted in a noticeably homogeneous basophilic stained...

  • Elimination of the Need for Urine Studies in the Screening Algorithm for Monoclonal Gammopathies by Using Serum Immunofixation and Free Light Chain Assays. Katzmann, Jerry A.; Dispenzieri, Angela; Kyle, Robert A.; Snyder, Melissa R.; Plevak, Matthew F.; Larson, Dirk R.; Abraham, Roshini S.; Lust, John A.; Melton III, L. Joseph; Rajkumar, S. Vincent // Mayo Clinic Proceedings;Dec2006, Vol. 81 Issue 12, p1575 

    OBJECTIVE: To determine the relative diagnostic contribution of urine assays as part of the screening algorithm for monoclonal gammopathies. PATIENTS AND METHODS: We Identified 428 patients with a monoclonal gammopathy and monoclonal urinary protein at initial diagnosis of plasma cell dyscrasia...

  • Deri Bulguları ileTanı Konulan Bir Multipl Myelom Olgusu. Erdoğan, Fatma Gülru; Tuğrul, Burcu; Gürler, Aysel; Heper, Aylin Okçu // Archives of the Turkish Dermatology & Venerology / Turkderm;2010, Vol. 44 Issue 4, p170 

    Multiple myeloma, being a malignant proliferation of plasma cells in the bone marrow, has clinical spectrum varying from monoclonal gammopathy with unknown significance to plasma cell leukemia. The presenting symptoms have usually been bone pain, pathologic fractures or repeating infections. In...

  • Elotuzumab: a new monoclonal antibody for multiple myeloma therapy. Staderini, Michela; Nozzoli, Chiara // Drugs & Cell Therapies in Hematology;2016, Issue 1, p68 

    For decades, since its first description, multiple myeloma represented a hard challenge for clinicians due to the scarce results obtained with conventional chemotherapies. Autologous stem cells transplantation and novel drugs such as immunomodulating drugs (IMIDs) and proteasome inhibitors (PIs)...

  • Multiple Myeloma of the Cricoid Cartilage. Yoskovitch, Adi; Al-Abdulhadi, Khaled; Wright, Erin D.; Watters, Andrew K.; Chagnon, Francoise // Journal of Otolaryngology;May/Jun1998, Vol. 27 Issue 3, p168 

    Presents a case of cricoid involvement in a patient with known multiple myeloma (MM), the most common form of the plasma cell dyscrasias. Symptoms of MM in the head and neck region; Categories of the disease when looking at plasma cell tumors of the head and neck; Treatment of MM; Alternative...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics